JHS Svendgaard Laboratories Ltd

JHS Svendgaard Laboratories, a microcap in the FMCG sector, has hit a new 52-week low, reflecting significant volatility and a cumulative drop over two days. The stock has underperformed compared to its sector and is trading below multiple moving averages, indicating ongoing market challenges.

JHS Svendgaard Laboratories has reported its financial results for the quarter ending December 2024, showing flat performance for the third quarter of FY24-25. While net sales for the half-year reached Rs 42.34 crore, reflecting a year-on-year growth of 27.41%, cash and cash equivalents have declined to Rs 5.82 crore, indicating liquidity challenges.

JHS Svendgaard Laboratories, a microcap FMCG company, has reported a negative performance in the second quarter of fiscal year 2024-2025. Key areas such as PBT, PAT, and PBDIT have seen a decline, along with a decrease in EPS and cash and cash equivalents. MarketsMOJO has given the company a 'Strong Sell' rating.

JHS Svendgaard Laboratories, a microcap FMCG company, reported a flat performance in the quarter ending June 2024. However, the company's net sales, operating profit, and efficiency have shown improvement compared to the previous quarters. The company's PBT and debtors turnover ratio have also shown positive trends.

JHS Svendgaard Laboratories, a microcap FMCG company, has reported a flat performance in the quarter ending March 2024, with a score of -5. However, the company's operating profit and profit margin have shown improvement. On the other hand, net sales and profit after tax have decreased, and the company's non-operating income is high.

JHS Svendgaard Laboratories, a microcap company in the FMCG industry, reported a negative financial performance for the quarter ending December 2023. The company's net sales and profit after tax have declined, while non-operating income is high. Investors should carefully evaluate these factors before making any investment decisions.

JHS Svendgaard Laboratories Ltd, a microcap FMCG company, has seen a surge in its stock price, reaching a 52-week high on January 31, 2024. The stock has consistently outperformed its sector and is currently trading higher than its moving averages. With a remarkable 1-year performance of 95.66%, the company shows potential for growth.

JHS Svendgaard Laboratories Ltd, a microcap FMCG company, reached a 52-week high on January 30, 2024. Despite a recent dip, the stock is still trading higher than its moving averages and has outperformed the Sensex by 88.95%. This showcases the company's strong growth and potential in the FMCG industry.

JHS Svendgaard Laboratories Ltd, a microcap company in the FMCG industry, has seen a surge in its stock price, reaching a 52-week high on January 29, 2024. According to MarketsMOJO, the stock is currently rated as a 'Sell'. It has outperformed the sector and its moving averages, showing strong potential for growth.

JHS Svendgaard Laboratories Ltd, a microcap FMCG company, has reached a 52-week high on January 25th, 2024, with a 19.93% return in the past two days. It outperformed the sector by 9.39% and is currently trading above its moving averages. However, MarketsMOJO has given a 'Sell' call, highlighting the need for investors to conduct their own research.

JHS Svendgaard Laboratories Ltd, a microcap FMCG company, has been making headlines as its stock price reached a 52-week high on January 23, 2024. The stock has been performing well, outperforming the sector by 4.38% and trading higher than its moving averages. Its 1-year performance of 61.57% showcases its strong growth potential.

JHS Svendgaard Laboratories Ltd, a microcap FMCG company, has seen a surge in its stock price, reaching a 52-week high of Rs 31 on January 20, 2024. Despite a 'Sell' call from MarketsMOJO, the company's performance has outperformed the sector by 2.59% and has seen a consecutive gain of 14.23% in the past three days. Its stock is currently trading higher than its moving averages and has shown a remarkable 48.12% increase in the past year, outperforming the Sensex's 17.99% performance.

JHS Svendgaard Laboratories, a microcap company in the FMCG industry, reported a decline of 0.53% in net sales and a growth of 73.36% in consolidated net profit in the quarter ended September 2023. The operating profit margin has improved, but there are areas where the company needs to improve.